Skip to main content
All lobbying clients

CHATTEM, INC D/B/A OPELLA

Lobbying client · New Jersey · filed 2025 to 2026

Healthcare related to nonprescription drugs and dietary supplements.

$1,080,000 Reported spend
7 Filings counted
1 Firms hired
6 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (64791), not by name.

 Firms hired 1
 Bills named in these filings 6
  • S 2529
    A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonpre…
    2 filings
  • HR 1219
    Oral Health Products Inclusion Act
    1 filing
  • HR 4273
    Over-the-Counter Monograph Drug User Fee Amendments
    1 filing
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    1 filing
  • S 2292
    Over-the-Counter Monograph Drug User Fee Amendments
    1 filing
  • S 3122
    Better FDA Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $350,000 2 filings
  • 2025 $730,000 5 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 5
  • Food & Drug Administration (FDA) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem